Zobrazeno 1 - 10
of 464
pro vyhledávání: '"Tito, Fojo"'
Autor:
Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, Mina Meseha, Izak Faiena, Yeun-Hee Anna Park, Glen McWilliams, Carol Luhrs, Kara N. Maxwell, Daniel Von Hoff, Susan E. Bates, Tito Fojo
Publikováno v:
EBioMedicine, Vol 107, Iss , Pp 105288- (2024)
Summary: Background: We aimed to assess real-world efficacy of the PARP inhibitor, olaparib, in US Veterans with metastatic prostate cancer (mPC) by leveraging the national data repository and evaluate a novel approach to assess treatment efficacy in
Externí odkaz:
https://doaj.org/article/334a7c499ee34aacbe5585cb079f89ea
Autor:
Eunhyeong Lee, Sophie O’Keefe, Alessandra Leong, Ha-Ram Park, Janani Varadarajan, Subrata Chowdhury, Shannon Hiner, Sungsoo Kim, Anahita Shiva, Richard A. Friedman, Helen Remotti, Tito Fojo, Hee Won Yang, Gavin Thurston, Minah Kim
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 20 (2023)
Improving the management of metastasis in pancreatic neuroendocrine tumors (PanNETs) is critical, as nearly half of patients with PanNETs present with liver metastases, and this accounts for the majority of patient mortality. We identified angiopoiet
Externí odkaz:
https://doaj.org/article/eaf9a3bca30a429d8677f001514daa1e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michal Mauda‐Havakuk, Elizabeth Levin, Elliot B. Levy, Venkatesh P. Krishnasamy, Victoria Anderson, Nidhi Jain, Hayet Amalou, Tito Fojo, Maureen Edgerly, Paul G. Wakim, Marybeth S. Hughes, Jaydira delRivero, Bradford J. Wood
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2259-2267 (2021)
Abstract Background To evaluate outcomes and survival rates in patients with metastatic adrenocortical carcinoma (ACC) who were treated with image‐guided locoregional treatments (IGLTs). Purpose To evaluate the overall survival (OS) and clinical im
Externí odkaz:
https://doaj.org/article/7b353160ff7743beb395c06f7e3e55af
Autor:
Tito Fojo, Lyn Huff, Thomas Litman, Kate Im, Maureen Edgerly, Jaydira del Rivero, Stefania Pittaluga, Maria Merino, Susan E. Bates, Michael Dean
Publikováno v:
BMC Medical Genomics, Vol 13, Iss 1, Pp 1-15 (2020)
Abstract Background Adrenocortical carcinoma (ACC) is a rare, often-aggressive neoplasm of the adrenal cortex, with a 14–17 month median overall survival. We asked whether tumors from patients with advanced or metastatic ACC would offer clues as to
Externí odkaz:
https://doaj.org/article/178a94f70ba546e1a2a2186d45d7c3c6
Autor:
Laurent Dercle, Matthew Fronheiser, Naiyer A. Rizvi, Matthew D. Hellmann, Sabine Maier, Wendy Hayes, Hao Yang, Pingzhen Guo, Tito Fojo, Lawrence H. Schwartz, Binsheng Zhao, David K. Leung
Publikováno v:
Journal of Thoracic Oncology. 18:587-598
Autor:
Harshraj Leuva, George Moran, Nader Jammaleddine, Mina Maseeha, Mengxi Zhou, Yunju Im, Ta-Chueh Rosenberg, Carol Luhrs, Susan Bates, Yeun-Hee Park, Tito Fojo, Izak Faiena
Background: The value of immune checkpoint inhibitors (PD1/PDL1 inhibitors; ICI) in treating prostate cancer (PC) is limited. We examined data from US Veterans with PC to assess disease response to ICIs as monotherapy or combined with abiraterone or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c402887f92a3f6ab45354a42e950e603
https://doi.org/10.21203/rs.3.rs-2883552/v1
https://doi.org/10.21203/rs.3.rs-2883552/v1
Autor:
Ashray Maniar, Alexander Z. Wei, Laurent Dercle, Harold H. Bien, Tito Fojo, Susan E. Bates, Lawrence H. Schwartz
Publikováno v:
Seminars in Oncology. 49:298-305
Autor:
Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S. Moskowitz, Dana E. Connors, Hao Yang, Lin Lu, Diane Reidy-Lagunes, Tito Fojo, Sanja Karovic, Michael L. Maitland, Geoffrey R. Oxnard, Lawrence H. Schwartz
Publikováno v:
European Journal of Cancer. 161:138-147
Autor:
Richard L. Piekarz, Susan E. Bates, Tito Fojo, William D. Figg, Monica Skarulis, John Wright, David Venzon, Sue Woo, Robin Frye, Deb Draper, James Reynolds, Kambiz Ghafourian, Cody J. Peer, Victoria Luchenko, Laleh Amiri-Kordestani
Supplementary Tables - PDF file 33K, Supplementary Table 1. Dose levels, dose administered on each treatment day, days 1,3, and 5 of a 21-day cycle, and number of patients treated on each dose level. Supplementary Table 2. Romidepsin toxicities found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ade7b0319a628d926a54a4d23879983
https://doi.org/10.1158/1078-0432.22449377
https://doi.org/10.1158/1078-0432.22449377